up and up juniors acetaminophen

Product NDC: 11673-160
11-digit product format: 116730160
Labeler code: 11673
Product ID: 11673-160_72804e03-4043-4188-85ac-9272f13856a3
Type: HUMAN OTC DRUG
Nonproprietary name: Acetaminophen
Dosage form: TABLET, CHEWABLE
Route: ORAL
Labeler: Target Corporation
Application: part343
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2015-10-15
Marketing end: 0000-00-00
Substance: ACETAMINOPHEN
Active strength: 160 mg/1
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 6 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	11673-160		I	Inactivated by FDA	2026-08-17
excluded product	product	11673-160		I	Inactivated by FDA	2026-08-17
excluded product	product	11673-160		D	Discontinued by firm	2026-08-17
excluded package	package	11673-160	11673-160-31	I	Inactivated by FDA	2026-08-17
excluded package	package	11673-160	11673-160-32	I	Inactivated by FDA	2026-08-17
excluded package	package	11673-160	11673-160-30	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 112 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	11673-160-30	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	11673-160-32	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	11673-160-31	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	11673-160-30	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	11673-160-32	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	11673-160-31	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	11673-160-30	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	11673-160-32	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	11673-160-31	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	11673-160-30	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	11673-160-32	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	11673-160-31	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	11673-160-30	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	11673-160-32	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	11673-160-31	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	11673-160-30	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	11673-160-32	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	11673-160-31	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	11673-160-30	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	11673-160-32	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	11673-160-31	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	11673-160-30	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	11673-160-32	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	11673-160-31	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	11673-160-30	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	11673-160-32	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	11673-160-31	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	11673-160-30	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	11673-160-32	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	11673-160-31	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
75d4bef7-334c-4a95-abb5-bff9def24114	Product name	2	20260112
7dea7767-9f52-b60a-5435-33cb9cc28bae	Product name	4	20250124
6338270f-96cb-0ecb-6fbb-0a9bc78001f4	Product name	7	20250116
11939cf5-0ea7-5df5-5127-00a7ce07fd7f	Product name	5	20250115
0ca83774-3f79-b837-5d6f-c210102f3bc8	Product name	6	20250114
88300afc-e1c4-ad17-c80b-4957f1b809a5	Product name	5	20250113
4eddd6ca-259a-4c6c-a3a4-2025015ce043	Product name	7	20240611
16cde546-8deb-4df2-a072-dab5566ede95	Product name	1	20231003
20ab58de-c64a-4ec2-9210-3aa3fae2b66f	Product name	1	20230808
a3631b20-02d1-41d7-8187-5e5e850b9e80	Product name	1	20230306
79e1734e-f721-4d46-978a-be382f771672	Product name	2	20230110
41b814f3-0166-1c53-c9ef-a0794c7daf9d	Product name	3	20221110
a590be26-846c-8659-a5a1-fb25907965dc	Product name	2	20221110
06cc817f-60e0-4473-8e6b-c44d11dc5af6	Product name	9	20220921
92ead9ae-674d-4eee-a492-c385d496891f	Product name	3	20220308
103b151b-b17f-42ac-8624-3ef62f5e2975	Product name	2	20200507
b8497372-efe9-9dde-fa2d-59be9761aa64	Product name	9	20200428
20c8cafe-5cfc-44f8-a9be-a664f437f780	Product name	2	20200225
3a16d77a-e865-468a-aedf-6e58913c1c21	Product name	3	20190619
2a0c98e1-033f-4e0d-a0da-b5291ffbe880	Product name	1	20190320
00d531e4-b130-8c52-eaf9-826cbb6f15dd	Product name	3	20190205
aa0f353d-f35e-62e4-4e1f-5b563f01c659	Product name	9	20190205
22d922aa-c443-d9f3-b23c-03b03a9ad31c	Product name	7	20181220
377068df-225f-7318-a910-a1987cdfa361	Product name	3	20170608
23475c0b-a5b5-4fec-b97f-acca901eae6a	Product name	1	20140718
105ef617-6fa4-6713-326f-72ec8a6b75a9	Product name	1	20140508
332e86c3-7875-ca6e-f934-2206d2b31996	Product name	1	20140508
3ed6b849-48b8-8899-c288-6eeb396123b6	Product name	1	20140508
47fd879b-91c5-e1e5-130f-29d082a871ec	Product name	1	20140508
53855190-7124-8179-f018-e792f7c27f28	Product name	1	20140508
7dfac40f-a405-cd2e-7c06-3059ec0e1092	Product name	1	20140508
84fb0b3d-1d72-b672-bc70-2b676a23e7e0	Product name	1	20140508
96c5169b-5b9d-547d-bf22-d688d91866e4	Product name	1	20140508
b8e0daf1-fb81-290b-c0bf-873be19ef775	Product name	1	20140508
c35d1ac8-8885-2ee1-6c52-5a715b242c00	Product name	1	20140508
c8753a88-edde-8e17-a396-705537b52cee	Product name	1	20140508
cd4f9ae2-1343-ecd2-ce0f-97db0c2b51ce	Product name	1	20140508
cf3a804d-0326-aa22-0142-c184b5657d85	Product name	1	20140508
d83c592c-dd97-4cbf-36ac-13da806684bd	Product name	1	20140508
e01133ad-4dcd-c7f3-454b-2ff569ee160a	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
11673-160-31	2020-01-31	C162847	48780-1	9d75b9d1-261f-f424-e053-dadaa90a57ce	up and up juniors’ acetaminophen melty tabs
11673-160-32	2020-01-31	C162847	48780-1	9d75b9d0-a38d-f424-e053-dadaa90a57ce	up and up juniors’ acetaminophen melty tabs

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
11673-160-31	up and up juniors acetaminophen	6 in 1 BLISTER PACK	TABLET, CHEWABLE	6	1
11673-160-31	up and up juniors acetaminophen	4 in 1 CARTON	TABLET, CHEWABLE	4	1
11673-160-32	up and up juniors acetaminophen	6 in 1 BLISTER PACK	TABLET, CHEWABLE	6	1
11673-160-32	up and up juniors acetaminophen	4 in 1 CARTON	TABLET, CHEWABLE	4	1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
11673-160-30	EA - Each	11673-160	b98ece78-ddb0-467a-97a4-bca53e0cfda8	1	2013-08-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DOCUSATE SODIUM	ACTIVE INGREDIENT	F05Q2T2JA0	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
SENNOSIDES	ACTIVE INGREDIENT	3FYP5M0IJX	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
DOCUSATE	ACTIVE MOIETY	M7P27195AG	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
SENNOSIDES	ACTIVE MOIETY	3FYP5M0IJX	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE	INACTIVE INGREDIENT	O7TSZ97GEP	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
CARNAUBA WAX	INACTIVE INGREDIENT	R12CBM0EIZ	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
MALTODEXTRIN	INACTIVE INGREDIENT	7CVR7L4A2D	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	SENNA LAXATIVE PLUS STOOL SOFTENER (DOCUSATE SODIUM, SENNOSIDES) TABLET [TARGET CORPORATION]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
11673-160	UP AND UP JUNIORS ACETAMINOPHEN (ACETAMINOPHEN) TABLET, CHEWABLE [TARGET CORPORATION]	1	Legacy NDC, 2 package rows	20160304_72804e03-4043-4188-85ac-9272f13856a3.zip
11673-160	UP AND UP JUNIORS ACETAMINOPHEN (ACETAMINOPHEN) TABLET, CHEWABLE [TARGET CORPORATION]	1	Legacy NDC, 2 package rows	20160303_525c218a-1882-42aa-97ba-2cfa0160fb67.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
362O9ITL9D	ACETAMINOPHEN	103-90-2	ACETAMINOPHEN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
477282	acetaminophen 160 MG Disintegrating Oral Tablet	PSN	525c218a-1882-42aa-97ba-2cfa0160fb67	1
477282	acetaminophen 160 MG Disintegrating Oral Tablet	PSN	72804e03-4043-4188-85ac-9272f13856a3	1
477282	acetaminophen 160 MG Disintegrating Oral Tablet	SCD	525c218a-1882-42aa-97ba-2cfa0160fb67	1
477282	acetaminophen 160 MG Disintegrating Oral Tablet	SCD	72804e03-4043-4188-85ac-9272f13856a3	1
477282	APAP 160 MG Disintegrating Oral Tablet	SY	525c218a-1882-42aa-97ba-2cfa0160fb67	1
477282	APAP 160 MG Disintegrating Oral Tablet	SY	72804e03-4043-4188-85ac-9272f13856a3	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
11673-160-31	11673016031	6 in 1 BLISTER PACK	Historical
11673-160-32	11673016032	6 in 1 BLISTER PACK	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Drug Facts	TARGET Corporation	2018-12-27	HUMAN OTC DRUG LABEL	3
up and up juniors’ acetaminophen melty tabs	Target Corporation	2015-01-16	HUMAN OTC DRUG LABEL	1
up and up juniors’ acetaminophen melty tabs	Target Corporation	2015-01-16	HUMAN OTC DRUG LABEL	1